DN2 cells from severely infected SARS-CoV-2 subjects had significantly higher levels of CD69 expression, but not CD86, when compared to individuals immunized against SARS-CoV-2 or those with mild infection (Figures 4A, B). The gene discussed is CD86; the disease is infection.